Here's the headline from the lead story in the business section of a nearby newspaper: "Celebrex tops Vioxx in study." PHILADELPHIA — New research suggests that top-selling pain reliever Celebrex does not carry the same heart attack risk as Vioxx, a similar drug pulled from the market in September because of safety concerns. Celebrex is a widely used drug for treating arthritis pain, so this is big news. But what's it doing in the business section? Part of the answer... Read more